Загрузка...
Interchangeability Evaluation of Multisource Ibuprofen Drug Products Using Biowaiver Procedure
The WHO biowaiver procedure for BCS Class II weak acids was evaluated by running two multisource IR ibuprofen drug products (Ibuprofen, 200 mg tablets, Tatchempharmpreparaty, Russia and Ibuprofen, 200 mg tablets, Biosintez, Russia) with current Marketing Authorizations (i.e. in vivo bioequivalent) t...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Medknow Publications & Media Pvt Ltd
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3374563/ https://ncbi.nlm.nih.gov/pubmed/22707831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0250-474X.95643 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|